Piramal Pharma Limited — Quarter and year ended March 31, 2026 (reported on April 28, 2026)
| Particulars | Three months ended March 31, 2026 (Refer note 8) | Three months ended December 31, 2025 (Unaudited) | Corresponding Three months ended March 31, 2025 (Refer note 8) | For the year ended March 31, 2026 (Audited) | For the previous year ended March 31, 2025 (Audited) |
|---|---|---|---|---|---|
| Revenue from operations | 1,489.06 | 1,195.81 | 1,689.80 | 4,782.01 | 5,285.71 |
| Other income (Net) (Refer Note 5) | 183.69 | 96.15 | 39.51 | 662.73 | 207.35 |
| Total Income | 1,672.75 | 1,291.96 | 1,729.31 | 5,444.74 | 5,493.06 |
| Cost of materials consumed | 234.93 | 347.06 | 336.72 | 1,342.70 | 1,596.93 |
| Purchases of stock-in-trade | 194.03 | 264.03 | 149.93 | 866.18 | 733.60 |
| Changes in inventories of finished goods, stock-in-trade and work-in-progress | 225.25 | (78.19) | 236.32 | (138.98) | (84.57) |
| Employee benefits expense | 166.55 | 187.80 | 198.96 | 744.82 | 736.19 |
| Finance costs | 19.50 | 16.84 | 30.56 | 79.95 | 114.56 |
| Depreciation and amortisation expense | 70.12 | 64.69 | 61.17 | 255.50 | 222.09 |
| Other expenses (Net) | 364.95 | 307.86 | 351.29 | 1,325.29 | 1,263.12 |
| Total Expenses | 1,275.33 | 1,110.09 | 1,364.95 | 4,475.46 | 4,581.92 |
| Profit before exceptional items and tax | 397.42 | 181.87 | 364.36 | 969.28 | 911.14 |
| Exceptional items (Refer note 6) | (65.57) | (26.94) | – | (92.51) | – |
| Profit before tax | 331.85 | 154.93 | 364.36 | 876.77 | 911.14 |
| Current tax (including prior year taxes) | 43.11 | 19.39 | 69.55 | 114.68 | 199.44 |
| Deferred tax (Net) | 27.11 | 6.63 | 17.54 | 62.08 | 20.30 |
| Total tax expenses | 70.22 | 26.02 | 87.09 | 176.76 | 219.74 |
| Profit after tax | 261.63 | 128.91 | 277.27 | 700.01 | 691.40 |
| Remeasurement of post employment benefit plans | (10.19) | 2.42 | (1.70) | (12.50) | (8.24) |
| Income tax impact on above | 2.56 | (0.61) | 0.42 | 3.15 | 2.07 |
| Deferred gains/(loss) on cash flow hedge | (3.35) | 3.65 | 19.66 | (35.25) | 15.60 |
| Income tax impact on above | 0.84 | (0.92) | (4.95) | 8.87 | (3.93) |
| Total Other Comprehensive Income/(Loss), net of tax expense | (10.14) | 4.54 | 13.43 | (35.73) | 5.50 |
| Total Comprehensive Income for the period | 251.49 | 133.45 | 290.70 | 664.28 | 696.90 |
| Paid-up Equity Share Capital (Face Value of Rs. 10/- each) | 1,327.16 | 1,325.83 | 1,324.35 | 1,327.16 | 1,324.35 |
| Other Equity | – | – | – | 6,813.97 | 6,128.19 |
| Basic EPS for the period/year (Rs.) | 1.97 | 0.97 | 2.09 | 5.28 | 5.22 |
| Diluted EPS for the period/year (Rs.) | 1.96 | 0.97 | 2.09 | 5.25 | 5.20 |
| Particulars | As at March 31, 2026 (Audited) | As at March 31, 2025 (Audited) |
|---|---|---|
| ASSETS | ||
| 1. Non-Current Assets | ||
| (a) Property, Plant & Equipment | 2,021.50 | 2,010.75 |
| (b) Capital Work in Progress | 101.51 | 77.68 |
| (c) Goodwill | 160.55 | 160.55 |
| (d) Intangible Assets | 687.36 | 604.91 |
| (e) Intangible Assets under development | 119.60 | 249.62 |
| (f) Right-of-use assets | 166.45 | 118.07 |
| (g) Financial Assets: | ||
| – (i) Investments | 3,486.05 | 3,105.31 |
| – (ii) Loans | 511.54 | 456.57 |
| – (iii) Other Financial Assets | 35.40 | 19.54 |
| (h) Income Tax Assets (Net) | 26.41 | 21.33 |
| (i) Other Non-Current Assets | 38.80 | 31.62 |
| Total Non-Current Assets | 7,355.17 | 6,855.95 |
| 2. Current Assets | ||
| (a) Inventories | 1,873.39 | 1,205.35 |
| (b) Financial Assets: | ||
| – (i) Investments | 93.55 | – |
| – (ii) Trade Receivables | 1,405.84 | 1,666.69 |
| – (iii) Cash & Cash equivalents | 559.03 | 163.87 |
| – (iv) Bank balances other than (iii) above | 15.29 | 13.97 |
| – (v) Loans | 22.73 | 12.52 |
| – (vi) Other Financial Assets | 56.07 | 81.63 |
| (c) Other Current Assets | 372.20 | 391.85 |
| Total Current Assets | 4,398.10 | 3,535.88 |
| Total Assets | 11,753.27 | 10,391.83 |
| EQUITY AND LIABILITIES | ||
| 1. Equity | ||
| (a) Equity Share capital | 1,327.16 | 1,324.35 |
| (b) Other Equity | 6,813.97 | 6,128.19 |
| Total Equity | 8,141.13 | 7,452.54 |
| 2. Liabilities | ||
| Non-Current Liabilities | ||
| (a) Financial Liabilities: | ||
| – (i) Borrowings | 420.86 | 356.84 |
| – (ii) Lease liabilities | 61.35 | 14.27 |
| (b) Deferred Tax Liabilities (Net) | 269.34 | 213.13 |
| (c) Provisions | 94.31 | 48.56 |
| Total Non-Current Liabilities | 845.86 | 632.80 |
| Current Liabilities | ||
| (a) Financial Liabilities: | ||
| – (i) Borrowings | 289.03 | 865.09 |
| – (ii) Lease liabilities | 15.01 | 6.98 |
| – (iii) Trade Payables | ||
| — (a) Total outstanding dues of Micro enterprises and small enterprises | 101.59 | 41.98 |
| — (b) Total outstanding dues of creditors other than Micro enterprises and small enterprises | 1,909.86 | 1,142.78 |
| – (iv) Other Financial Liabilities | 100.06 | 128.27 |
| Total Financial Liabilities | 2,415.55 | 2,185.10 |
| (b) Other Current Liabilities | 304.65 | 78.54 |
| (c) Provisions | 42.21 | 42.85 |
| (d) Current Tax Liabilities (Net) | 3.87 | – |
| Total Current Liabilities | 2,766.28 | 2,306.49 |
| Total Equity & Liabilities | 11,753.27 | 10,391.83 |
| Particulars | For the year ended March 31, 2026 (Audited) Rs. in Crores | For the year ended March 31, 2025 (Audited) Rs. in Crores |
|---|---|---|
| A. CASH FLOW FROM OPERATING ACTIVITIES | ||
| Profit before tax | 876.77 | 911.14 |
| Adjustments for: | ||
| – Depreciation and amortisation expense | 239.78 | 212.58 |
| – Amortisation of Right-of-use assets | 15.71 | 9.51 |
| – Provision written back | (55.71) | (18.26) |
| – Finance Costs | 79.95 | 114.56 |
| – Interest Income on Financial assets | (136.19) | (112.44) |
| – Dividend received | (40.18) | (51.45) |
| – Government Grant Income | (6.11) | (5.51) |
| – (Gain)/Loss on Measurement of financial assets at FVTPL | (1.57) | 0.17 |
| – Interest Income on Income Tax Refund | (1.90) | – |
| – (Profit)/Loss on Sale of Property Plant and Equipment | (1.02) | 0.13 |
| – Write down/(back) of Inventories | (7.60) | 44.85 |
| – Profit on Sale of Current Investment (Net) | (6.92) | (1.93) |
| – Expected Credit Loss on Trade Receivables | 5.07 | 15.67 |
| – Intangible asset under development write off | – | 25.94 |
| – Employee Share Based Expenses | 18.91 | 18.41 |
| – Unrealised foreign exchange (gain) / loss | (343.29) | 12.28 |
| – Exceptional Items (Refer Note 6) | 92.51 | – |
| Operating Cashflows Before Working Capital Changes | 728.21 | 1,175.65 |
| Adjustment for Changes in Working Capital | ||
| Adjustments for (Increase) / Decrease in operating assets | ||
| – Trade receivables | 310.04 | (350.98) |
| – Other Current Assets | 25.76 | 14.45 |
| – Other Non Current Assets | 0.58 | 0.74 |
| – Other Financial Assets – Non Current | (15.86) | 0.07 |
| – Inventories | (660.44) | (97.16) |
| – Other Financial Assets – Current | 38.28 | 12.37 |
| Adjustments for Increase / (Decrease) in operating liabilities | ||
| – Trade Payables | 849.33 | 89.81 |
| – Non – Current provisions | 33.25 | 8.09 |
| – Other Current Financial Liabilities | (60.78) | 24.49 |
| – Other Current Liabilities | 226.11 | (93.75) |
| – Current provisions | (27.58) | (0.72) |
| Cash Generated from Operations | 1,446.89 | 783.06 |
| – Taxes Paid (Net of Refunds) | (118.77) | (234.29) |
| Net Cash Generated from Operating Activities | 1,328.12 | 548.77 |
| B. CASH FLOW FROM INVESTING ACTIVITIES | ||
| Purchase of Property, Plant and Equipment / Intangible Assets (including Capital Work in Progress and Capital advances) | (297.55) | (282.78) |
| Proceeds from Sale of Property, Plant and Equipment / Intangible Assets | 9.63 | 0.90 |
| Purchase of Current Investments: | ||
| – in Mutual Funds | (1,191.02) | (729.06) |
| Proceeds from Sale of Current Investments: | ||
| – in Mutual Funds | 1,105.96 | 792.10 |
| Interest Received | 25.47 | 105.47 |
| Fixed deposits placed | – | (4.02) |
| Maturity of Deposits | – | 3.00 |
| Dividend received [Net of TDS of Rs 4.02 crores (March 25: Rs 5.15 crores)] | 36.16 | 46.31 |
| Investment in equity shares of subsidiary | * | * |
| Investment in equity shares of body corporates | (1.68) | (1.27) |
| Loans to related parties (Net of repayments) | (4.80) | (480.63) |
| Net Cash used in Investing Activities | (317.83) | (549.98) |
| C. CASH FLOW FROM FINANCING ACTIVITIES | ||
| Proceeds from Non-Current Borrowings – Receipts | 535.78 | 200.00 |
| Proceeds from Non-Current Borrowings – Payments | (393.23) | (233.33) |
| Proceeds/ (Repayments) from Current Borrowings | (650.00) | 120.00 |
| Lease payments – Principal | (11.68) | (8.07) |
| Lease payments – Interest | (4.40) | (2.06) |
| Proceeds from Issuance of Equity shares to subsidiary | 3.49 | 2.80 |
| Finance Costs Paid | (76.55) | (126.61) |
| Dividend Paid | (18.54) | (14.47) |
| Net Cash Generated/(used in) from Financing Activities | (615.13) | (61.74) |
| Net Increase/(Decrease) in Cash & Cash Equivalents [(A)+(B)+(C)] | 395.16 | (62.94) |
| Opening Cash and Cash Equivalents | 163.87 | 228.80 |
| Add: Effect of exchange fluctuation on cash and cash equivalents | – | (1.98) |
| Closing Cash and Cash Equivalents | 559.03 | 163.87 |
| Cash and Cash Equivalents Comprise of: | ||
| Cash on Hand | 0.03 | 0.04 |
| Balance with Scheduled Banks – Current Accounts | 197.46 | 159.22 |
| Balance with Scheduled Banks – Deposit Accounts (original maturity less than 3 months) | 225.00 | – |
| Cheques on hand | 6.27 | 4.61 |
| Remittance in transit | 130.27 | – |
| Total | 559.03 | 163.87 |
| Particulars | For the year ended March 31, 2026 (Audited) | For the year ended March 31, 2025 (Audited) |
|---|---|---|
| STATEMENT OF AUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2026 (Rs. in Crores) | ||
| Revenue from operations | 2,751.77 | 2,139.87 |
| Other Income | 46.06 | 43.24 |
| Total Income | 2,797.83 | 2,183.11 |
| Cost of Materials Consumed | 482.59 | 505.48 |
| Purchase of Stock-in-Trade | 336.03 | 376.84 |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | 237.05 | (96.01) |
| Employee benefits expense | 586.02 | 599.85 |
| Finance Costs | 82.99 | 89.24 |
| Depreciation, amortisation and impairment charge | 218.38 | 212.74 |
| Other Expenses (Net) | 649.57 | 557.98 |
| Total Expenses | 2,592.63 | 2,246.13 |
| Profit/(Loss) before share of net profit of associates, exceptional items and tax | 205.20 | (63.02) |
| Share of net profit of associates | 13.58 | 10.26 |
| Profit/(Loss) before exceptional items and tax | 218.78 | (52.76) |
| Exceptional items (Refer Note 6) | (175.77) | (41.11) |
| Profit/(Loss) before tax | 43.00 | (93.87) |
| Current |